Freenome is a private biotech company dedicated to advancing early cancer detection through innovative blood tests. Leveraging cutting-edge artificial intelligence and scientific research, Freenome's approach aims to make cancer screening more accessible. By focusing on early diagnosis, the company strives to improve treatment outcomes for patients.